Silk proteins-based startup 'Fibroheal Woundcare' uplifts Rs. 6.3 crore Funding in pre-Series A
In its pre-Series A funding round, surgeons, doctors, and bankers contributed a combined Rs. 6.3 crore to the medical device startup Fibroheal Woundcare, which is based on silk proteins.
Additionally, the company has committed an additional Rs. 10 crore from both current and potential new investors.
The money raised will be put toward expanding its workforce, accelerating its go-to-market plan, and funding its medical device product pipeline.
Fibroheal, a company founded in 2017 by Vivek Mishra and Bharat Tandon, has products in over 19 states and more than 500 hospitals in India. Additionally, the business has expanded to sell its goods on a number of e-commerce websites.
The company's product line, which includes, among other things, foams, mesh, and powders, is used to treat a variety of wounds, including bed sores and infected C-section wounds, that are acute, chronic, traumatic, post-operative, non-healing, or difficult to heal.
Previously, Fibroheal has raised money from KITVEN, CCAMP, and Telama Investments, its current promoters.
The field of health and wellness is seeing rapid growth in the woundcare sector. With a unique technology built on "Natural Silk," devoted leadership, and a capable team, Fibroheal is well-positioned to dominate this market, according to KK Narayanan, who also participated in this funding round.
Previously, Narayanan co-founded Kottaram Agrofoods (Soulfull Cereals), which was acquired by Tata Consumer Products, and built Metahelix Life Sciences, which was acquired by Rallis India.
According to a 2024 report by research firm Mordor Intelligence, the fundraise coincides with a notable expansion in the Indian wound care market, propelled by an increase in chronic diseases, rising healthcare expenditures, and awareness of wound care solutions.
Additionally, the company has committed an additional Rs. 10 crore from both current and potential new investors.
The money raised will be put toward expanding its workforce, accelerating its go-to-market plan, and funding its medical device product pipeline.
Fibroheal, a company founded in 2017 by Vivek Mishra and Bharat Tandon, has products in over 19 states and more than 500 hospitals in India. Additionally, the business has expanded to sell its goods on a number of e-commerce websites.
The company's product line, which includes, among other things, foams, mesh, and powders, is used to treat a variety of wounds, including bed sores and infected C-section wounds, that are acute, chronic, traumatic, post-operative, non-healing, or difficult to heal.
Previously, Fibroheal has raised money from KITVEN, CCAMP, and Telama Investments, its current promoters.
The field of health and wellness is seeing rapid growth in the woundcare sector. With a unique technology built on "Natural Silk," devoted leadership, and a capable team, Fibroheal is well-positioned to dominate this market, according to KK Narayanan, who also participated in this funding round.
Previously, Narayanan co-founded Kottaram Agrofoods (Soulfull Cereals), which was acquired by Tata Consumer Products, and built Metahelix Life Sciences, which was acquired by Rallis India.
According to a 2024 report by research firm Mordor Intelligence, the fundraise coincides with a notable expansion in the Indian wound care market, propelled by an increase in chronic diseases, rising healthcare expenditures, and awareness of wound care solutions.
.jpg "Innovating Legal Solutions to Safeguard your Business")
